The FDA today released a safety alert on its website. Please contact us immediately if you have been using testosterone products for low testosterone due to aging and have experienced any adverse side effects. To view the entire article, visit our Low-T website.
Home » Blog Morelli Law » Class Actions » FDA Issues Warning About Using Testosterone Products; Requires Labeling Change To Inform Of Possible Increased Risk Of Heart Attack And Stroke
About the Author
Sara A. Mahoney
Sara Mahoney concentrates her practice in the areas of nursing home litigation, personal injury, medical malpractice, employment discrimination, and consumer class actions. Sara also does appellate work for the firm and has helped research and compose briefs submitted to the New York Appellate Division, First Department, the New York Appellate Division, Second Department, and the 9th Circuit Court of Appeals. In a recent appeal to the New York Appellate Division, First Department, the Court upheld pain and suffering damages totaling $20 million for a single plaintiff – the highest amount to be upheld for such damages in New York State.